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Background
Several authors have recently reported that resistin, a
novel adipokine, may be associated with insulin resistance
in HIV patients. Our objective was to evaluate resistin
dysfunction in correlation with insulin sensitivity, lipid
abnormalities and markers of inflammation in a cohort of
adult HIV infected patients who were under complex
combined therapy (cART).
Methods
We performed a transversal study that used the follow-
ing inclusion criteria: non-diabetic patients with docu-
mented HIV infection, undergoing stable cART for at
least 6 months. Clinical, metabolic, inflammatory and
immuno-virological patterns were assessed (age, sex,
body mass index, HIV load, actual and nadir CD4, dura-
tion of HIV infection and antiretroviral therapy, lipid
panel, C-reactive protein - CRP). Resistin levels were
evaluated using KAPME Biosource EASIA. In order to
test the sensitivity to insulin we used the QUICKI index,
the best surrogate marker after glucose clamp index.
Parametric and non-parametric variables were described
using means (±Standard Deviation - SD) and medians
(Interquartile Ratio - IQR), respectively.
Results
We enrolled 94 patients (56.4% males, 43.6% females),
with a mean age of 31.9 (±13.5) years. The median time
from HIV diagnostic was 63 (74) months; the median
time of treatment was 60 (50) months. More than half
of patients (72.3%) had undetectable HIV load and the
median CD4 count was 492 (419)/cmm. The mean level
of resistin was 6 (±2.6) ng/mL. The most frequent resis-
tin dysfunction, after adjusting the results by sex and
age, was hyporesistinemia (40.2%); hyperresistinemia was
less frequent (17.4%). Most patients had insulin resistance
(66.3%), based on QUICKI levels below the cut-off point
of 0.33. We found no relation between QUICKI values
and resistin, in a linear regression model (R = 0.054, p =
0.614) or correlation between the presence of insulin
resistance and resistin dysfunction (p = 0.320). Lipid
metabolism abnormalities were not influenced by resistin
dysfunction. Resistin serum values were positively corre-
lated with the levels of CRP (R = 0.21, p = 0.05).
Conclusion
In our cohort of young HIV infected patients, insulin
resistance was not mediated by resistin dysfunction,
contrary to recent reports, but may contribute to an
increased inflammatory profile.
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